These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25556489)

  • 41. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F; Yin LX
    Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
    Wang LJ; Wang SG; Deng TX
    Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression of genes involved in hepatocellular carcinoma chemoresistance is affected by mitochondrial genome depletion.
    Gonzalez-Sanchez E; Marin JJ; Perez MJ
    Mol Pharm; 2014 Jun; 11(6):1856-68. PubMed ID: 24824514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis.
    Wu LL; Cai WP; Lei X; Shi KQ; Lin XY; Shi L
    J Cell Commun Signal; 2019 Mar; 13(1):99-112. PubMed ID: 30030687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
    Lin XQ; Huang ZM; Chen X; Wu F; Wu W
    Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
    Wang P; Zhuang C; Huang D; Xu K
    Oncol Rep; 2016 Jul; 36(1):247-52. PubMed ID: 27222047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell.
    Xu N; Zhang J; Shen C; Luo Y; Xia L; Xue F; Xia Q
    Biochem Biophys Res Commun; 2012 Jul; 423(4):826-31. PubMed ID: 22713463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
    Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
    J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
    Jiang C; Long J; Liu B; Xie X; Kuang M
    Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
    Wu S; Zhang T; Du J
    Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.
    Ma J; Wang T; Guo R; Yang X; Yin J; Yu J; Xiang Q; Pan X; Tang H; Lei X
    J Drug Target; 2015; 23(6):519-24. PubMed ID: 25714665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
    Wu J; Zhang L; Li H; Wu S; Liu Z
    Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
    Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L
    Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.
    Zhang JJ; Wang CY; Hua L; Yao KH; Chen JT; Hu JH
    Int J Clin Exp Pathol; 2015; 8(5):5168-74. PubMed ID: 26191213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.